AMORPHOUS FLUTICASONE 2-FUROATE, PHARMACEUTICAL COMPOSITIONS THEREOF AND ITS CONVERSION TO THE CRYSTALLINE UNSOLVATED FORM

Details for Australian Patent Application No. 2003244451 (hide)

Owner GLAXO GROUP LIMITED

Inventors BIGGADIKE, Keith; COOTE, Steven, John; NOGA, Brian; VAN OORT, Michiel, Mary

Pub. Number AU-A-2003244451

PCT Number PCT/GB03/00461

PCT Pub. Number WO2003/066655

Priority 60/354,143 04.02.02 US

Filing date 4 February 2003

Wipo publication date 2 September 2003

International Classifications

C07J 031/00 Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing sulfur

A61K 031/56 - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61P 005/44 Drugs for disorders of the endocrine system

Event Publications

18 September 2003 Complete Application Filed

  Priority application(s): 60/354,143 04.02.02 US

25 September 2003 Application Open to Public Inspection

  Published as AU-A-2003244451

10 March 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003244452-METHOD OF PROMOTING NEURONAL GROWTH

2003244450-FORMULATIONS FOR INHALATION